Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs



Rating:

Share or cite this content

Citations should be made in the following way:
J. Skowronek, M. Kubaszewska, A. Chichel, M. Kanikowski (Poznan, Poland). HDR endobronchial brachytherapy (HDR-BT) in the management of advanced lung cancer – comparison of different protocols. Eur Respir J 2008; 32: Suppl. 52, 619

Member's Comments

No comment yet.

Related content which might interest you: Bronchoscopic high-dose-rate brachytherapy Source: Eur Respir Mon; 2010: 48: 173–189 Year: 2010 Endobronchial brachytherapy in the treatment of malignant lung tumours Source: Eur Respir J 2004; 24: 348-352 Year: 2004 High dose rate endobronchial brachytherapy in the palliative management of bronchial cancer - comparison of different doses Source: Eur Respir J 2001; 18: Suppl. 33, 375s Year: 2001 External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non small cell lung cancer Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007 Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Iodine-125 seed brachytherapy combined with pembrolizumab for advanced non-small-cell lung cancer after failure of first-line chemotherapy. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer Source: Eur Respir J 2010; 36: 965-967 Year: 2010 High-dose-rate brachytherapy (HDR-BT) in the treatment of lung cancer – Greatpoland Cancer Center experience Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Assessment of endoscopic response subsequent to brachytherapy and external beam irradiation for non-small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 375s Year: 2001 Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Electromagnetically navigated bronchoscopy and endobronchial ultrasound for brachytherapy of inoperable peripheral lung cancer – a prospective feasibility and safety study Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer Year: 2007 SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020 Palliative treatment of locally advanced non small cell lung cancer with weekly fraction radiotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 496s Year: 2005 Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers Source: Eur Respir J 2006; 28: 200-218 Year: 2006 High-dose-rate endobronchial brachytherapy (HD-BQT) in radical or palliative therapy for lung cancer Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014 Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC Source: Eur Respir J 2012; 39: 1039-1042 Year: 2012 Radiotherapy vs. radio-chemotherapy of the inoperable non small cell lung cancer - a phase-III-study Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001 Optimal integration of chemo- and radiotherapy in small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009